As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

Artificial intelligence is no longer just spotting tumors a little faster than humans. In study after study, machine learning systems are uncovering hidden patterns in cancer data that even veteran ...

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.

The prototype of a new machine that can detect tumors in women with dense breast tissue has been developed by researchers from UCL, Newcastle Hospitals and Newcastle University, in partnership with ...

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated ...

OncoInv has signed a distribution partnership with MaxBloch Clinical Laboratories to introduce the OncoSeek® multi-cancer ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

What if people could detect cancer and other diseases with the same speed and ease of a pregnancy test or blood glucose meter? Researchers at the Carl R. Woese Institute for Genomic Biology are a step ...

Conventional diagnostic tools, such as ultrasound, MRI, PET, CT scans, and scintigraphy, often identify cancer only at later stages. These methods can be expensive, expose patients to radiation, and ...